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Abstract External Quality Assessment (EQA) schemes are national or transnational 
programmes designed to control the analytical performance of clinical laboratories and to 
maintain inter-laboratory variability within acceptable limits. In such EQA programmes, 
participants are usually grouped by the type of assay technique/equipment they use. The 
coefficient of variation (CV) is a simple tool for comparing the inter-laboratory 
reproducibility of such techniques: the lower the CV, the better the analytical performance. 
Serum protein electrophoresis, a laboratory test profile consisting of five fractions (albumin, 
α1, α2, β and γ globulins) summing up to 100% of total proteins, can also be assayed in 
different ways depending on the media or the analytical principle. We propose a multivariate 
coefficient of variation for comparing the performance of electrophoretic techniques in EQA, 
thus extending the univariate CV concept. First, the compositional nature of electrophoretic 
data requires a one-to-one transformation from the 5-dimensional to the 4-dimensional space. 
Next, robust estimations of the mean and the covariance matrix are needed to avoid the effect 
of outliers. The new approach is illustrated on electrophoretic datasets from the French and 
Belgian national EQA programmes. 
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To control the analytical performance of clinical laboratories, External Quality Assessment 
(EQA) programmes have been implemented worldwide for many years. These programmes, 
traditionally organized by healthcare authorities or external agencies, have greatly improved 
the inter-laboratory compatibility of tests results and hence clinical decision making.  
It is known that assay techniques and equipments used by the participants are a source of 
inter-laboratory imprecision and bias. Not only do calibrators, reagents or kits utilized affect 
the results, but also other parameters such as the temperature can explain additional 
variability. Despite international harmonization guidelines and recommendations, the fact 
that laboratories continue to use different assay methods is an important factor to take into 
account in EQA programmes. Therefore, EQA organizers generally group participants 
according to the analytical principle or equipment they use for doing the tests. The statistical 
analysis of the data is then carried out for each ―analytical‖ group separately. A ―robust‖ 
mean (M) and standard deviation (SD) are calculated, so that for each individual laboratory 
result (x) a distance SDMxd /  can be derived. Laboratories exceeding a certain critical 
distance d* from their peers in the group will be considered as ―poor-performers‖. As 
summary statistics, EQA organizers also compute for each group the coefficient of variation 
(CV), in order to compare the analytical performance of the various techniques.  
Serum protein electrophoresis was only recently implemented in EQA schemes, in 
particular for controlling the detection and characterization of monoclonal immunoglobulins. 
Electrophoresis separates serum proteins into five fractions, specifically albumin, α1, α2, β 
and γ globulins, reported as absolute values (g/L) or as relative proportions (expressed in %) 
of total serum protein. When expressed in percent, the five electrophoretic fractions sum up 
to 100% [1]. As for other analytes, the electrophoretic technique is an important factor likely 
to influence the final results. These techniques essentially depend on the media (agarose gel, 
cellulose acetate electrophoresis [1]) or on the analytical principle (e.g., the recently 
developed capillary zone electrophoresis [2-4]). In a recent paper [5], we proposed a robust 
multivariate method to analyse EQA electrophoresis data. This method supersedes the 
traditional approach of viewing each fraction separately (as for ordinary tests) by providing a 
global assessment of each electrophoretic profile.  
The present work was specifically oriented towards the generalization of the coefficient of 
variation as a way to compare the inter-laboratory variability of electrophoretic techniques, as 
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done for single laboratory tests. This is achieved in two steps. First, because of the 
compositional nature of electrophoretic data (their fractions sum up to 100%), a one-to-one 
transformation is applied to the fractions to break the linear constraint and keep only four 
variables for subsequent calculations. Second, a robust mean and covariance matrix is 
calculated for the 4-dimensional vector of transformed data. Finally, a multivariate ―robust‖ 
CV is computed by using a Mahalanobis distance between the mean vector and the origin. 
The comprehensive development is illustrated on serum protein electrophoresis material from 





Serum protein electrophoresis results were obtained from laboratories participating in the 
2004 French and Belgian EQA programmes for the same control sample (04G9). It was a 
liquid specimen of human origin, which contained a monoclonal IgM-lambda paraprotein 
concentrated to 5 g/L, emphasizing a narrow peak in the zone of γ-globulin of the 
electrophoretic profile. There were 2376 participants (out of 2965 registered laboratories in 
the field of immuno-pathology) who actually returned their electrophoresis results to the 
EQA agencies. Among these, 93 (4%) electrophoretic profiles for which the sum of the five 
fractions was not equal to 100% up to rounding errors (say ± 0.2%) were discarded from the 
analysis and considered as not satisfactory. For all other electrophoretic profiles, prior to the 
statistical analysis, the five fractions were multiplied by a common factor 
fractions) observed of sum(%100  to sum up to exactly 100%.  
A total of 28 different assay techniques were reported by the participants according to 
media/analytical principle, stain colour and reagent. Only techniques including at least 
20n  participants were considered in this work. There were 13 such techniques 
corresponding to a total of 2196 participants (see Table 1). The 13 assay techniques were 
classified in four major categories: agarose gel-acid blue (n = 227, 10%), agarose gel-amido 
black (n = 1600, 73%), cellulose acetate membrane-Ponceau S (n = 207, 9%) and capillary 
zone electrophoresis (n = 162, 7%). As seen in Table 1, there were three techniques based on 
agarose gel electrophoresis staining with acid blue and five with amido black, three 
techniques supplied with cellulose acetate membrane staining with Ponceau S and two 
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recently developed capillary zone electrophoreses. Most participating laboratories performed 
protein electrophoresis using agarose gel electrophoresis (amido black).  
 
 
Table 1. Distribution into four categories of the 13 serum protein electrophoretic 
techniques reported in the 2004 French and Belgian EQA programmes with at least 20 





Agarose gel electrophoresis (Acid blue) (n = 227)  
Helena Titan
®
 Gel SPE-IFE 121 
Helena SAS-MX SP-10   86 
Helena SAS-MX SP-10 β1-β2   20 
  
Agarose gel electrophoresis (Amido black) (n = 1600)  
Beckman-Coulter Paragon SPE   41 
Helena Titan
®
 Gel Proteins (HR)   88 
Sebia Hydragel
®
 Protein K20 487 
Sebia Hydragel
®
 β1-β2 Hydrasys   81 
Sebia Hydragel
®
 (Hydratest) (HR) Protein Hydrasys 903 
  
Cellulose acetate electrophoresis (Ponceau S) (n = 207)  
Helena Titan
®
 III Proteins 141 
Biomidi Midifilm & Midiplaque Proteins   30 
Sebia Sebiagel   36 
  
Capillary zone electrophoresis (n = 162)  
Beckman-Coulter Paragon CZE
®
 2000   65 
Sebia Capillarys
®




Univariate coefficients of variation 
 
The coefficient of variation (CV) is a widely used measure in EQA, and in laboratory 
medicine in general, to assess and compare the reproducibility of techniques and equipments. 
By definition,  
MSDCV  , (1) 
where M  represents the mean concentration of the analyte in the control sample and SD the 
inter-laboratory variability. Since the coefficient of variation is usually expressed in percent, 
Eq. (1) will be multiplied by 100%. Robust estimates of M  and SD are generally required, 
because EQA datasets often entail outliers or blunders which seriously bias their estimation. 
Traditionally, 50PM  , the sample median, and  257574.0 PPSD  , where P25 and P75 are 
the first and third quartiles of the sample of results, respectively [6]. As an example, Table 2 
displays the robust estimates of M  and SD  for each electrophoretic fraction as obtained 
from the 903 participants using the ―Sebia Hydragel® (Hydratest) (HR) Protein Hydrasys‖ 
technique. The corresponding values for all assay techniques are given in Appendix 1. 
 
Table 2. Robust estimates of mean, standard deviation and coefficient of variation for each 
electrophoretic fraction in the group of laboratories using the ―Sebia Hydragel® (Hydratest) 
(HR) Protein Hydrasys‖ technique (n = 903 laboratories) 
 Electrophoretic fraction (%) 
 Albumin α1 α2 β γ 
Median 63.40 2.30 9.70 8.40 16.40 
Standard deviation   3.03 0.30 0.74 0.74   1.55 
Coefficient of variation (%)a   4.8 12.9 7.6 8.8   9.5 
a as obtained from Eq. (1) multiplied by 100% 
 
Once reliable estimates of M and SD are obtained, they can be plugged into Eq. (1) yielding 
a robust estimate of the CV (see Table 2). Univariate CVs for each electrophoretic fraction 
and each electrophoretic technique are displayed in Table 3. It is seen that the smallest CVs 
are always observed for the albumin fraction (range: 2.0 – 8.4%), while the largest CVs are 
found for the α1-globulin fraction (range: 7.4 – 30.9%) except for ―Beckman-Coulter Paragon 
SPE‖. When focussing on the electrophoretic techniques, the CVs of albumin, β and γ 
fractions for the ―Beckman-Coulter Paragon CZE® 2000‖ capillary zone electrophoresis were 
lower than for the other techniques. Moreover, the other capillary zone electrophoresis 
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technique, namely ―Sebia Capillarys® β1-β2/β1-β2+‖, showed high precision for the albumin, 
α2, β and γ fractions. The lowest CVs for the α1 and α2 globulins were obtained by using 
―Beckman-Coulter Paragon SPE‖. The highest CVs of albumin and α2-globulin were from 
―Helena SAS-MX SP-10 β1-β2‖ agarose gel electrophoresis (acid blue). For α1-globulin, the 
highest value (30.9%) was observed in ―Helena Titan® III Proteins‖, followed by ―Helena 
Titan
®
 Gel Proteins (HR)‖ technique (29.7%). The techniques of ―Helena Titan® Gel SPE-
IFE‖ and ―Biomidi Midifilm & Midiplaque Proteins‖ provided the highest values for the β-
fraction (17.5%) and the γ-fraction (11.8%), respectively. 
 
Table 3. Robust univariate coefficient of variation (%) of each electrophoretic fraction by 
technique in the French and Belgian EQA programmes (sample 04G9). Electrophoretic 
techniques are listed by increasing CV of the albumin fraction 
  CV (%)
a
 of electrophoretic fraction 
Electrophoretic technique n Albumin α1 α2 β γ 
Beckman-Coulter Paragon CZE
®
 2000 65 2.0   8.9   6.7   4.5   2.4 
Sebia Capillarys
®
 β1-β2/β1-β2+ 97 2.6 16.9   6.5   7.9   3.8 
Sebia Hydragel
®
 β1-β2 Hydrasys 81 3.6 11.1   6.7   7.4   9.9 
Beckman-Coulter Paragon SPE 41 3.9   7.4   6.5   8.3   9.2 
Sebia Hydragel
®
 (Hydratest) (HR) Protein Hydrasys 903 4.8 12.9   7.6   8.8   9.5 
Helena Titan
®
 III Proteins 141 4.9 30.9 13.6   8.8   8.7 
Helena SAS-MX SP-10 86 5.2 19.8 11.4 10.9   8.9 
Helena Titan
®
 Gel Proteins (HR) 88 5.3 29.7 11.0 14.8   7.8 
Sebia Hydragel
®
 Protein K20 487 5.5 15.4   8.8   9.4 11.4 
Helena Titan
®
 Gel SPE-IFE 121 5.9 23.7 12.8 17.5   9.9 
Biomidi Midifilm & Midiplaque Proteins 30 6.1 17.1 10.8   5.6 11.8 
Sebia Sebiagel 36 6.4 23.5 16.9 13.6 11.6 
Helena SAS-MX SP-10 β1-β2 20 8.4 19.2 17.3 10.7   8.2 
a CV values are derived from Eq. (1) multiplied by 100% 
 
While it is convenient and straightforward to calculate the CVs of the five fractions by 
technique, it would be more appropriate to provide an overall assessment of the various 
electrophoretic techniques and to rank them in some way. This can be achieved by computing 
a multivariate CV for each technique, which accounts for the linear constraint of the 5 
fractions and for the correlations between them. In addition, the multivariate CV should not 
be affected by outlying electrophoretic profiles in the dataset. 
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The multivariate coefficient of variation 
 
Let  51 ,, XX X  denote the 5-dimensional electrophoretic profile, where the variables 
iX  ( 5,,1i ) stand for the albumin, α1, α2, β and γ electrophoretic fractions (expressed in 
%), respectively, and satisfy the relation %10054321  XXXXX . Denote by 
 51 ,, xx x  the mean and by xS  the variance-covariance matrix of vector X . A 
literature search reveals that little attention has been paid to the multivariate coefficient of 
variation despite its potential importance. In 1960, Reyment [7] proposed a multivariate 
generalization of the CV by defining the ratio of the 2p-root of the determinant of xS  (here 
5p ) to the length of x , namely 25
2
1 xx  . Van Valen [8, 9] however criticized 
Reyment’s approach and suggested another formula, valid in all cases, in which the 
numerator of Reyment’s formula is replaced by the square-root of the sum of the variances 




1 SDSD  . Van Valen’s approach, 
while facile to compute, ignores the covariance elements of the xS  matrix. Following a 
suggestion made by Voinov and Nikulin [10] in a totally different context, we chose to define 
the multivariate coefficient of variation by the expression (multiplied by 100%) 
xSx
11  xMCV  (2) 
where the quantity xSx 1 x  represents the Mahalanobis distance of the mean x  to the origin. 
Eq. (2) is invariant under change of scale and reduces to Eq. (1) when 1p . However, it 
requires that the matrix xS  is invertible, which is not the case for electrophoretic profiles. In 
a previous paper of our group [5], we avoided this problem by working with a 4-dimensional 
electrophoretic profile, merely by discarding one of the fractions. Unfortunately, if we use 
this approach, Eq. (2) yields a different CVM value for each fraction deleted. We strived to 
circumvent this problem by proceeding with a 2-step procedure as described hereafter. 
Step 1. Electrophoresis data transform. The fact that the five electrophoretic fractions sum 
up to 100% makes the multivariate statistical analysis unreliable [11]. The linear constraint 
imposed on the five fractions locates these fractions on a so-called simplex space, which is a 
subset of the real space. It follows that the covariance matrix, based on the five fractions, is 
singular and not invertible. Therefore, there is a need to transform the constrained data into 
an unconstrained real space. Among the family of log-ratio transformations, three are worth 
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mentioning, the additive log-ratio (ALR) [11], the centered log-ratio (CLR) [12] and the 
isometric log-ratio (ILR) transformation [13]. In the present work, we decided to opt for the 
ILR transform which overcomes the problems of asymmetry of the ALR and of collinearity 
of the CLR transforms [13]. Let  41 ,, YY Y  denote the 4-dimensional vector obtained by 

















Y  ( 4,,1i ). (3) 
It should be noted that any zero electrophoretic fractions in Eq. (3) are disallowed. As 
observed in Eq. (3), the fractions are transformed from five percentages to four dimensionless 
quantities. An illustration of the use of Eq. (3) is given in Appendix 2. It is also to be 
remarked that the Yi values depend on the order in which the five fractions are included, 
while there should be no difference for the final results. After transformation, let 
 41 ,, yy y  and yS  denote respectively the sample mean and variance-covariance matrix 
of Y. Observe that now yS  can be inverted while xS  could not. 
Step 2. Robust multivariate estimation. As already mentioned, EQA organizers are 
traditionally facing the problem of outlying results. This also holds for electrophoretic 
profiles. The classical mean and covariance matrix (even after the transform above) can be 
markedly affected even by a single ―poor-performer‖, emphasizing the need for robust 
estimates [5]. There are plenty of robust methods available, but one of the most attractive 
rests upon the minimum covariance determinant (MCD) concept developed by Rousseeuw 
[14]. In addition, the MCD method can also be applied for compositional data [15]. This 
approach shows many advantages: high robustness, fast algorithm (FAST-MCD) and affine 
equivariant estimators [16]. According to the FAST-MCD algorithm, the MCD approach 
consists in finding h observations (in this study, h = 0.75n) whose classical covariance matrix 
provides the lowest determinant. The initial location estimate is then the average of these h 
points and the initial scatter estimate is their covariance matrix. Afterwards, the initial 
covariance matrix is multiplied by a consistency factor to obtain multivariate normality and a 
correction factor to be unbiased for small sample sizes [17]. The final covariance matrix yS  
is obtained by using a weighting step to achieve better efficiency (see ―covMcd‖ function in 
the ―robustbase‖ package of R 2.9.2 [18]). From the matrix yS , it is convenient to derive the 
correlation matrix yR  which is easier to interpret for the user. As a reminder, the correlation 
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between two variables is equal to the covariance between the two variables divided by the 
product of their standard deviations. 
The MCD estimates will differ according to which fraction is used as the reference basis for 
the ILR-transformation. However, in our case, this does not matter since the final robust 
estimate of the multivariate CV will always be the same. We applied the MCD method to 
each electrophoretic technique to obtain robust estimates of the mean ( y ), covariance matrix 
(
yS ) and correlation matrix ( yR ). As an illustration, Table 4 gives the results for the ―Sebia 
Hydragel
®
 (Hydratest) (HR) Protein Hydrasys‖ technique (n = 903 laboratories). The MCD 
estimates were obtained similarly for all other electrophoretic techniques (data not shown). It 
should be realized that the correlations between the 
iY  variables are not the correlations 
between the electrophoretic fractions. 
 
Table 4. Robust multivariate estimates of mean ( y ), covariance matrix 
( yS ) and correlation matrix ( yR ) obtained from laboratories using the 
―Sebia Hydragel® (Hydratest) (HR) Protein Hydrasys‖ technique 
( 903n  laboratories) 
 ILR- transformed variable 
 Y1 Y2 Y3 Y4 




Y1 0.014 0.0022 0.00035 0.0026 
Y2 0.31 0.0035 0.00028 0.0017 
Y3 0.038 0.061 0.0060 0.00061 
Y4 0.43 0.56 0.16 0.0025 
a
 Correlations between new variables are given in italic values 
 
After getting the MCD mean y  and covariance matrix yS  from the ILR-transformed 
results, the value of the multivariate coefficient of variation can be directly calculated for 
each technique by the following equation (multiplied by 100%) 
ySy
11  yMCV . (4) 
An estimation of the standard error (SE) of CVM can be obtained by the bootstrap method 
[19]. However, this computer intensive method is sensitive to the presence of outlying 
observations. Therefore, outliers were first removed from the dataset based on the approach 
recommended in [17] and then the bootstrap was applied to each cleaned dataset. 
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Table 5. Robust multivariate CVs for the protein electrophoretic techniques in the French 
and Belgian EQA programmes (sample 04G9). The values of CVM have been sorted by 
increasing order of magnitude. The standard error of the CVM is obtained by the bootstrap 
method for the cleaned datasets (1000 iterations). 
Electrophoretic technique   n Multivariate CV 
a
 ± SE (%) 
Beckman-Coulter Paragon CZE
®
 2000   65 2.45 ± 0.21 
Beckman-Coulter Paragon SPE   41 2.54 ± 0.25 
Sebia Hydragel
®
 (Hydratest) (HR) Protein Hydrasys 903 3.54 ± 0.10 
Sebia Hydragel
®
 β1-β2 Hydrasys   81 4.14 ± 0.28 
Sebia Capillarys
®
 β1-β2/β1-β2+   96
 b 4.38 ± 0.28 
Sebia Hydragel
®
 Protein K20 487 5.01 ± 0.18 
Helena SAS-MX SP-10   86 5.29 ± 0.53 
Biomidi Midifilm & Midiplaque Proteins   30 6.02 ± 0.69 
Helena Titan
®
 Gel SPE-IFE 121 6.06 ± 0.45 
Helena Titan
®
 Gel Proteins (HR)   88 6.95 ± 0.68 
Helena Titan
®
 III Proteins 141 7.23 ± 0.45 
Sebia Sebiagel   36 7.81 ± 0.88 
Helena SAS-MX SP-10 β1-β2   20 7.82 ± 1.22 
a CV values are derived from Eq. (4) multiplied by 100% 
b One laboratory with a zero fraction was discarded 
 
 
The robust multivariate CV was calculated for each electrophoretic technique using Eq. (4) 
and expressed in percent. Results are displayed in Table 5 by increasing order of magnitude 
of CVM together with their standard errors. The ―Beckman-Coulter Paragon CZE
®
 2000‖ 
capillary zone electrophoresis technique showed the lowest CV (2.45%). By contrast, the 
―Helena SAS-MX SP-10 β1-β2‖ agarose gel electrophoresis (acid blue) technique had the 
highest CVM (7.82%) but was only based on 20 participants (SE of 1.22%).  
The values of CVM (± SE) were also calculated for the four major electrophoretic 
categories: agarose gel-acid blue (5.9 ± 0.29%), agarose gel-amido black (4.4 ± 0.08%), 
cellulose acetate membrane-Ponceau S (7.8 ± 0.39%) and capillary zone electrophoresis (3.7 
± 0.18%). Note that the fully ―automated‖ capillary zone electrophoretic technique showed 




The systematic implementation of EQA surveys to control the analytical performance of 
clinical laboratories generates vast amount of data. The statistical analysis of EQA data 
pursues several goals: first to provide reliable estimates of the mean (i.e., the concentration of 
the control specimen) and of the standard deviation (i.e., the inter-laboratory variability); 
next, to unveil laboratories with outlying results (so called, poor-performers) as compared to 
the other participants, so that corrective actions or even sanctions can be taken; finally, to 
highlight unsatisfactory analytical techniques, which can be progressively removed from the 
market and replaced by better ones. In the latter case, the CV is a useful and widely accepted 
indicator for comparing the performance of assay techniques or instruments. 
Traditionally, EQA schemes have been mainly focussing on single tests (e.g., substrates, 
enzymes, hormones) so that statistical methods (including robust methods) are pretty 
straightforward to apply and are easily understood by the laboratory medicine community. 
When it comes to laboratory profiles, like serum protein electrophoresis, things get somewhat 
more complicated as profile components (electrophoretic fractions) have to be analysed and 
interpreted globally and not separately.  
In a previous paper of our group [5], we proposed a novel statistical method to analyse 
EQA electrophoresis data and to get reliable estimates of the mean and dispersion 
(correlation) matrix of electrophoresis results sent by the EQA participants and identify 
laboratories with out-of-range profiles. The present work purposed to compare the analytical 
performance of electrophoretic techniques used by laboratories by calculating a multivariate 
coefficient of variation. The multivariate CV developed in this paper followed a suggestion 
made by Voinov and Nikulin in a totally different context. It is equal to the inverse of the 
square root of the Mahalanobis distance of the mean to the origin. This CV has interesting 
properties. It is interpreted as a univariate CV and expressed in percent: the lower the CV, the 
better the analytical variability. It is invariant under change of scale (e.g., change of units). It 
reduces to the classical univariate CV if the profile contains only one test. Nonetheless, it 
suffers from a few drawbacks. It is highly sensitive to outliers, so that a robust approach is 
required to obtain a reliable estimate. It can not be calculated if the tests of the profile are 
linearly related (as it is the case for protein electrophoresis) because the covariance matrix 
can not be inverted. By deleting one fraction of the electrophoretic profile, however, the 
covariance matrix is no longer singular. Unfortunately, the CVM will be different for each 
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fraction removed. To circumvent these shortcomings, we applied a two-step procedure: (1) 
the ILR-transform of the 5 electrophoretic fractions to derive a 4-dimensional profile, and (2) 
to use the MCD method for estimating the mean vector and covariance matrix of the new 4-
dimensional vector. The multivariate CV can then be derived by utilizing the latter estimates. 
The method has proven to work quite well and experience has shown that a sample of at least 
20 laboratories is needed to get reliable robust estimates. For groups with less than 20 
participants, the MCD method is shakier and we recommend simply computing classical 
estimates of the mean and covariance matrix. Results however have to be considered with 
utmost care.  
The multivariate coefficient of variation was illustrated on a database from the joint French 
and Belgian EQA electrophoretic programmes, thus allowing having a sufficient number of 
laboratories within each electrophoretic technique group. The novel approach enabled to rank 
these techniques by increasing inter-laboratory variability, which could hardly have been 
done on the basis of the univariate CVs of the 5 fractions. Multivariate CVs ranged between 
2.45% to 7.82% and given the large sample sizes in some of the groups, significant CV 
differences could be highlighted between several techniques.  
We believe that the method proposed in this work is quite feasible since the ILR-transform 
is easy to apply and the R programme to calculate the robust MCD estimates is a freeware 
that can be downloaded. It was remarked that the value of the multivariate CV does not 
depend on which fraction of the electrophoretic profile was chosen as the reference (here we 
selected γ-globulin but any other fraction could have been used). Our method is applicable 
whenever a multivariate profile is available. In case data are not compositional, the first step 
can be skipped and the user can straightforwardly proceed with the robust estimation of the 
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Table 6 displays the medians and SDs of the electrophoretic profile (control sample 04G9) 
for all thirteen electrophoretic techniques considered. 
 
Table 6. Robust univariate estimates of the mean and standard deviation (in parentheses) of 
each electrophoretic fraction for the thirteen techniques from the 2004 French and Belgian 
EQA programmes (sample 04G9) 
  Electrophoretic fraction (%) 
Electrophoretic technique n Albumin α1 α2 β γ 
Helena Titan
®
 Gel SPE-IFE 121 60.3 (3.55) 2.5 (0.59) 9.8 (1.26) 9.3 (1.63) 18.6 (1.85) 
Helena SAS-MX SP-10 86 59.7 (3.10) 2.9 (0.57) 9.1 (1.04) 9.3 (1.02) 18.8 (1.67) 
Helena SAS-MX SP-10 β1-β2 20 58.1 (4.88) 2.6 (0.50) 9.4 (1.63) 10.2 (1.09) 19.9 (1.63) 
Beckman-Coulter Paragon SPE  41 61.4 (2.37) 3.0 (0.22) 9.2 (0.60) 8.7 (0.73) 18.2 (1.67) 
Helena Titan
®
 Gel Proteins (HR) 88 59.0 (3.12) 2.5 (0.76) 10.1 (1.12) 9.8 (1.44) 18.9 (1.47) 
Sebia Hydragel
®
 Protein K20 487 62.3 (3.40) 2.4 (0.37) 9.2 (0.81) 9.4 (0.88) 16.6 (1.89) 
Sebia Hydragel
®
 β1-β2 Hydrasys 81 63.4 (2.29) 2.0 (0.22) 8.9 (0.59) 9.0 (0.67) 16.4 (1.63) 
Sebia Hydragel
®
 (Hydratest) (HR) 
     Protein Hydrasys 
903 63.4 (3.03) 2.3 (0.30) 9.7 (0.74) 8.4 (0.74) 16.4 (1.55) 
Helena Titan
®
 III Proteins 141 57.9 (2.81) 2.4 (0.74) 9.8 (1.33) 10.1 (0.89) 19.6 (1.70) 
Biomidi Midifilm & Midiplaque 
      Proteins 
30 61.0 (3.74) 2.6 (0.44) 7.3 (0.80) 8.6 (0.48) 19.6 (2.31) 
Sebia Sebiagel 36 62.6 (3.98) 2.6 (0.61) 7.7 (1.29) 9.0 (1.22) 18.6 (2.15) 
Beckman-Coulter Paragon  
      CZE
®
 2000 
65 56.7 (1.15) 5.9 (0.53) 9.9 (0.66) 8.4 (0.38) 18.9 (0.46) 
Sebia Capillarys
®




To illustrate the use of Eq. (3), consider the following electrophoretic profile: %1.631 X , 
%4.22 X , %7.93 X , %4.84 X  and %4.165 X  (total sum = 100%). Then, the 
transformed data write successively  
  31.2ln21 211  XXY  
  19.0ln32 3212  XXXY   
  26.0ln43 43 3213  XXXXY  
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